WEST LAFAYETTE, Ind. - Purdue researchers have devised a way to capture the finer details of complex cell processes by using tiny synthetic particles known as dendrimers, a technology that could lead to more targeted treatment for cancer.
A precise understanding of how cells engulf small particles, a process known as endocytosis, could help researchers improve drug delivery and reveal the mechanisms of viruses. But the particles "eaten" by cells and the proteins that control cell entry pathways are too little for conventional technologies to detect.